 Innoviva Inc NASDAQ: INVA has agreed to acquire La Jolla Pharmaceutical Company NASDAQ: LJPC for 5.95 per share, representing a premium of approximately 70 to the 30-day volume-weighted average price. Innoviva will also pay an incremental 0.28 per share for additional. 